Bowman Bagley
CIK: 0002117210
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CollPlant Biotechnologies Ltd
Discretionary Trading P&L
Holdings
Transaction History (0 total)
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
Bowman Bagley files insider reports with the SEC as VP Commercial North America of CollPlant Biotechnologies Ltd (CLGN).
About Bagley Bowman
Bagley Bowman (SEC CIK 0002117210) files insider reports with the SEC as VP Commercial North America of CollPlant Biotechnologies Ltd (CLGN).
Signal8 holds 1 ownership filing by Bagley Bowman, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Bagley Bowman's filings is in REHOVOT.
Other insiders filing for CollPlant Biotechnologies Ltd (CLGN)
- Shlomi Ruty Ben, Director
- Rotem Eran, Deputy CEO and CFO
- Abelis Bar Berta, VP Legal
- Evans Hugh M, Director
- Tal Yehiel, Chief Executive Officer
- Lask Alisa, Director